Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minoru Tada

Showing results (191-200 of 258) with videos related to

Pageof 26
Sort By:
Cancer Chemotherapy and Pharmacology|August 22, 2014
A phase I trial of gemcitabine, S-1 and LV combination (GSL) therapy in advanced pancreatic cancerYousuke Nakai, Hiroyuki Isayama, Kei Saito, et al.
Journal of Gastroenterology|August 2, 2011
A large volume of visceral adipose tissue leads to severe acute pancreatitisYoko Yashima, Hiroyuki Isayama, Takeshi Tsujino, et al.
Neuron|June 16, 2010
An Arf-like small G protein, ARL-8, promotes the axonal transport of presynaptic cargoes by suppressing vesicle aggregationMatthew P Klassen, Ye E Wu, Celine I Maeder, et al.
Digestive Diseases and Sciences|January 17, 2014
Slow pull versus suction in endoscopic ultrasound-guided fine-needle aspiration of pancreatic solid massesYousuke Nakai, Hiroyuki Isayama, Kenneth J Chang, et al.
Scientific Reports|March 4, 2018
Assessing the Heterogeneity of the Fc-Glycan of a Therapeutic Antibody Using an engineered FcγReceptor IIIa-Immobilized ColumnMasato Kiyoshi, Jose M M Caaveiro, Minoru Tada, et al.
Journal of Gastroenterology|May 15, 2010
Endoscopic papillary balloon dilation for bile duct stone removal in patients 60 years old or youngerTakeshi Tsujino, Haruhiko Yoshida, Hiroyuki Isayama, et al.
Medical Oncology (Northwood, London, England)|May 31, 2018
A phase II trial of gemcitabine, S-1 and LV combination (GSL) neoadjuvant chemotherapy for patients with borderline resectable and locally advanced pancreatic cancerKei Saito, Hiroyuki Isayama, Yoshihiro Sakamoto, et al.
Journal of Gastroenterology|November 2, 2011
Different subtypes of intraductal papillary mucinous neoplasm in the pancreas have distinct pathways to pancreatic cancer progressionDai Mohri, Yoshinari Asaoka, Hideaki Ijichi, et al.
Journal of Gastroenterology|January 29, 2013
Management of dysfunctional covered self-expandable metallic stents in patients with malignant distal biliary obstructionOsamu Togawa, Hiroyuki Isayama, Takeshi Tsujino, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 31, 2013
Diabetes is a useful diagnostic clue to improve the prognosis of pancreatic cancerSuguru Mizuno, Yousuke Nakai, Hiroyuki Isayama, et al.
Pageof 26

Showing results (191-200 of 258) with videos related to

Sort By:
Pageof 26
Cancer Chemotherapy and Pharmacology|August 22, 2014
A phase I trial of gemcitabine, S-1 and LV combination (GSL) therapy in advanced pancreatic cancerYousuke Nakai, Hiroyuki Isayama, Kei Saito, et al.
Journal of Gastroenterology|August 2, 2011
A large volume of visceral adipose tissue leads to severe acute pancreatitisYoko Yashima, Hiroyuki Isayama, Takeshi Tsujino, et al.
Neuron|June 16, 2010
An Arf-like small G protein, ARL-8, promotes the axonal transport of presynaptic cargoes by suppressing vesicle aggregationMatthew P Klassen, Ye E Wu, Celine I Maeder, et al.
Digestive Diseases and Sciences|January 17, 2014
Slow pull versus suction in endoscopic ultrasound-guided fine-needle aspiration of pancreatic solid massesYousuke Nakai, Hiroyuki Isayama, Kenneth J Chang, et al.
Scientific Reports|March 4, 2018
Assessing the Heterogeneity of the Fc-Glycan of a Therapeutic Antibody Using an engineered FcγReceptor IIIa-Immobilized ColumnMasato Kiyoshi, Jose M M Caaveiro, Minoru Tada, et al.
Journal of Gastroenterology|May 15, 2010
Endoscopic papillary balloon dilation for bile duct stone removal in patients 60 years old or youngerTakeshi Tsujino, Haruhiko Yoshida, Hiroyuki Isayama, et al.
Medical Oncology (Northwood, London, England)|May 31, 2018
A phase II trial of gemcitabine, S-1 and LV combination (GSL) neoadjuvant chemotherapy for patients with borderline resectable and locally advanced pancreatic cancerKei Saito, Hiroyuki Isayama, Yoshihiro Sakamoto, et al.
Journal of Gastroenterology|November 2, 2011
Different subtypes of intraductal papillary mucinous neoplasm in the pancreas have distinct pathways to pancreatic cancer progressionDai Mohri, Yoshinari Asaoka, Hideaki Ijichi, et al.
Journal of Gastroenterology|January 29, 2013
Management of dysfunctional covered self-expandable metallic stents in patients with malignant distal biliary obstructionOsamu Togawa, Hiroyuki Isayama, Takeshi Tsujino, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|May 31, 2013
Diabetes is a useful diagnostic clue to improve the prognosis of pancreatic cancerSuguru Mizuno, Yousuke Nakai, Hiroyuki Isayama, et al.
Pageof 26